Analytical Treatment Interruption (ATI) to Assess the Immune System's Ability to Control HIV in Participants Who Became HIV-infected During the HVTN 704/HPTN 085 AMP Study
Clinical trial NCT04801758 · COMPLETED
Trial details
- NCT number
- NCT04801758
- Sponsor
- HIV Vaccine Trials Network
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-22
- Primary completion
- 2024-07-22
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.